Beschreibung
Comparative efficacy of different curcumin formulations for ulcerative colitis is explored across available trials. Nano-curcumin and phospholipid-bound preparations may offer improved colonic bioavailability.
Figure 23
ChartSource Paper
The Use of Curcumin as a Complementary Therapy in Ulcerative Colitis: A Systematic Review of Randomized Controlled Clinical Trials.Cite This Figure
![Figure 23: Comparative efficacy of different curcumin formulations for ulcerative colitis is explored across available trials. Nano-curcumin and phospholipid-bound preparations may offer improved colonic bioavailability.]() > Source: Mariana Roque Coelho et al. "The Use of Curcumin as a Complementary Therapy in Ulcerative Colitis: A Systemat." *Nutrients*, 2020. PMID: [32751776](https://pubmed.ncbi.nlm.nih.gov/32751776/)
<figure> <img src="" alt="Comparative efficacy of different curcumin formulations for ulcerative colitis is explored across available trials. Nano-curcumin and phospholipid-bound preparations may offer improved colonic bioavailability." /> <figcaption>Figure 23. Comparative efficacy of different curcumin formulations for ulcerative colitis is explored across available trials. Nano-curcumin and phospholipid-bound preparations may offer improved colonic bioavailability.<br> Source: Mariana Roque Coelho et al. "The Use of Curcumin as a Complementary Therapy in Ulcerative Colitis: A Systemat." <em>Nutrients</em>, 2020. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/32751776/">32751776</a></figcaption> </figure>